Mangohealth
3 known investors
San Francisco mobile health company whose app and enterprise platform help patients manage medications and improve adherence.
Also known as Mango Health
Investors · 3
Also in the syndicate · 2
Company profile
researched Aug 2026Mango Health is a San Francisco-based digital health company focused on medication management and patient engagement. Its enterprise platform uses mobile software to engage patients and improve rates of adherence to prescribed treatment regimens, and it works with healthcare organizations to help patients understand their medications, build healthier habits and improve outcomes.
The company's first consumer product is a mobile application, initially released on iPhone, that applies triggers and rewards drawn from social gaming to medication management. Features include daily reminders timed to a patient's dosing schedule, self-reporting of adherence (including photographing medication containers), a health journal for tracking exercise and daily activities, alerts about potential drug-drug interactions, and a social comparison element showing how a user's adherence compares with others. The team draws on backgrounds from Google, Castlight Health and mobile game company ngmoco, combining mobile software development with persuasive design.
Founding story
Co-founded by CEO Jason Oberfest and VP of Engineering Gerald Cheong, with a team of veterans from Google, Castlight Health and mobile game company ngmoco.
Business model
Enterprise platform sold to healthcare organizations alongside a free-to-use consumer mobile app; the company partners with care providers, health plans, pharmaceutical companies and self-insured employers to engage patients, reduce repeat visits, lower costs of care and improve clinical outcomes.
Traction
Launched in 2013 with an iPhone app promoted by Apple on the App Store from May 2013, and established partnerships with a leading U.S. integrated care delivery system, a national pharmacy benefit manager and a top U.S. health plan.
Latest developments
In May 2014 the company closed a $5.25 million Series A led by Kleiner Perkins Caufield & Byers, with KPCB General Partner Dr. Beth Seidenberg joining the board; proceeds were earmarked for engineering, content development, product marketing and account management supporting health industry partnerships.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positioned at the intersection of consumer technology and healthcare as a medication adherence and patient engagement provider, addressing chronic disease management, which the company states accounts for 75% of U.S. healthcare spending.
Use of game-like triggers and rewards and persuasive design to drive daily engagement in medication management, which its lead investor characterized as producing daily usage patterns and adherence lift not previously seen in the category.
Technology
Mobile applications built with persuasive design techniques adapted from social gaming, incorporating scheduled medication reminders, photo-based self-reporting, a health journal, and drug interaction alerts, layered on an enterprise patient-engagement platform.
Go-to-market
Consumer distribution through mobile app stores, where the iPhone app has been promoted by Apple since May 2013, combined with enterprise partnerships with large healthcare organizations including a U.S. integrated care delivery system, a national pharmacy benefit manager and a top U.S. health plan.
Patients managing prescription medications and supplements, reached through enterprise customers including integrated care delivery systems, pharmacy benefit managers, health plans, pharmaceutical companies and self-insured employers.
Geography
Headquartered at One Ferry Building, Suite 255, San Francisco, California, with a U.S. focus.
History
The company participated in the Rock Health accelerator program in 2012. Its first consumer product, an iPhone app, launched in 2013 and has been featured by Apple on the App Store since May 2013. Before its Series A it raised seed financing from Floodgate Fund, First Round Capital, Baseline Ventures, Bullpen Capital and individual investors, and in May 2014 it closed a $5.25 million Series A led by Kleiner Perkins Caufield & Byers.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsMango Health announced a $5.25 million Series A financing led by KPCB, to be used for engineering, content development, product marketing and account management.
$5.3M source ↗
KPCB General Partner Dr. Beth Seidenberg joined Mango Health's board of directors in connection with the Series A.
Mango Health's first consumer product, an iPhone application for medication adherence, has been promoted by Apple on the App Store since May 2013.
The company took part in the Rock Health accelerator program for healthcare technology startups.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 6
primary sources listed
- Mango Health | Re-Imagining TB Carereimaginingtbcare.org · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Mangohealth do?
- San Francisco mobile health company whose app and enterprise platform help patients manage medications and improve adherence.
- Who are Mangohealth's investors?
- Mangohealth's investors include Bullpen Capital.